Answers are grounded in this paper and cite their sources.
Review examines propellant-free solution and dry powder inhaler technologies for pulmonary drug delivery, highlighting how device selection and usability drive clinical benefit.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Myrna Dolovich (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: